Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Follow-Up Questions
Smith & Nephew PLC의 CEO는 누구입니까?
Mr. Deepak Nath은 2022부터 회사에 합류한 Smith & Nephew PLC의 Chief Executive Officer입니다.
SNN 주식의 가격 성능은 어떻습니까?
SNN의 현재 가격은 $36.18이며, 전 거래일에 decreased 0.43% 하였습니다.
Smith & Nephew PLC의 주요 사업 주제나 업종은 무엇입니까?
Smith & Nephew PLC은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Smith & Nephew PLC의 시가총액은 얼마입니까?
Smith & Nephew PLC의 현재 시가총액은 $15.3B입니다
Smith & Nephew PLC는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 18명의 분석가가 Smith & Nephew PLC에 대한 분석 평가를 실시했으며, 이는 6명의 강력한 매수, 8명의 매수, 9명의 보유, 0명의 매도, 그리고 6명의 강력한 매도를 포함합니다